The Bruton's Tyrosine Kinase Inhibitor Evobrutinib Demonstrates Superior Efficacy in Targeting Compartmentalized Neuroinflammation Compared to Anti-CD20 Treatment Hania Kebir, Cen Li, Michael May,Molly Church, Ursula Boschert Shafaatian,Jorge AlvarezNEUROLOGY（2023）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
